NASDAQ:XRAY - Dentsply Sirona Stock Price, Price Target & More

$50.62 +0.35 (+0.70 %)
(As of 04/19/2018 07:42 AM ET)
Previous Close$50.27
Today's Range$49.82 - $51.13
52-Week Range$48.25 - $68.98
Volume1.45 million shs
Average Volume2.40 million shs
Market Capitalization$11.43 billion
P/E Ratio18.90
Dividend Yield0.70%
Beta1.26

About Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona logoDENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:XRAY
CUSIP24903010
Phone717-845-7511

Debt

Debt-to-Equity Ratio0.24%
Current Ratio2.10%
Quick Ratio1.45%

Price-To-Earnings

Trailing P/E Ratio18.90
Forward P/E Ratio18.61
P/E Growth2.22

Sales & Book Value

Annual Sales$3.99 billion
Price / Sales2.88
Cash Flow$11.3244 per share
Price / Cash4.47
Book Value$28.86 per share
Price / Book1.75

Profitability

EPS (Most Recent Fiscal Year)$2.66
Net Income$-1,550,000,000.00
Net Margins-39.39%
Return on Equity8.35%
Return on Assets5.61%

Miscellaneous

Employees16,100
Outstanding Shares227,370,000

How to Become a New Pot Stock Millionaire

Dentsply Sirona (NASDAQ:XRAY) Frequently Asked Questions

What is Dentsply Sirona's stock symbol?

Dentsply Sirona trades on the NASDAQ under the ticker symbol "XRAY."

How often does Dentsply Sirona pay dividends? What is the dividend yield for Dentsply Sirona?

Dentsply Sirona announced a quarterly dividend on Wednesday, February 14th. Investors of record on Thursday, March 29th will be given a dividend of $0.0875 per share on Friday, April 13th. This represents a $0.35 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date of this dividend is Wednesday, March 28th. View Dentsply Sirona's Dividend History.

How were Dentsply Sirona's earnings last quarter?

Dentsply Sirona (NASDAQ:XRAY) posted its quarterly earnings results on Thursday, March, 1st. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.01. The medical instruments supplier had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. Dentsply Sirona had a positive return on equity of 8.35% and a negative net margin of 39.39%. The business's revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.67 EPS. View Dentsply Sirona's Earnings History.

When is Dentsply Sirona's next earnings date?

Dentsply Sirona is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Dentsply Sirona.

What price target have analysts set for XRAY?

14 brokerages have issued 12 month target prices for Dentsply Sirona's stock. Their predictions range from $55.00 to $81.00. On average, they anticipate Dentsply Sirona's share price to reach $67.00 in the next year. View Analyst Ratings for Dentsply Sirona.

What are Wall Street analysts saying about Dentsply Sirona stock?

Here are some recent quotes from research analysts about Dentsply Sirona stock:
  • 1. Jefferies Group LLC analysts commented, "Dynavax provided Phase 1b/2 updates on TLR9 agonist, SD-101 in combination with Keytruda, for head and neck squamous cell carcinoma (HNSCC) and metastatic melanoma at AACR." (4/16/2018)
  • 2. Barrington Research analysts commented, "We are currently modeling adjusted EPS of $2.70 and this is unchanged versus our previous modeling. We suspect that the company will be able to overcome whatever modest dilution comes with this deal over the balance of 2018. That said, we have made some modest adjustments to our quarterly modeling and have attached a model, which is a bit more back-end loaded than previously. We are doing this in part to account for any additional costs associated with the efforts to put this transaction together as well as general conservatism associated with prior disclosures by management relative to the company’s ongoing efforts to work down its inventory levels with certain key distribution channels." (3/27/2018)
  • 3. According to Zacks Investment Research, "Over the last year, DENTSPLY SIRONA traded below the broader industry in terms of prices. The company's higher capital expenditure on product development and tough competition are expected to put margins under pressure. Unfavorable foreign exchange rate and integration risks are the major headwinds in the near term. However robust performance by the company’s flagship dental implants, CAD/CAM systems, imaging systems, treatment centers and orthodontic product platforms hold considerable promise over the long haul. Emerging markets like Asia-Pacific & the Middle East offer healthy growth opportunities on a long-term basis, as they remain vastly untapped with low dental products penetration. The company’s agreements with MedTech bigwigs Patterson Companies in Canada are likely to drive sales. DENTSPLY SIRONA has recently witnessed a rebound in sales in Asia, particularly Japan, and strong growth in Russia. Over the last year, DENTSPLY" (1/8/2018)

Who are some of Dentsply Sirona's key competitors?

Who are Dentsply Sirona's key executives?

Dentsply Sirona's management team includes the folowing people:
  • Ms. Maureen J. MacInnis, Chief HR Officer & Sr. VP (Age 57)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 58)
  • Mr. Nicholas William Alexos, Principal Accounting Officer, Exec. VP & CFO (Age 54)
  • Mr. Robert J. Size, Interim Pres & COO (Age 59)
  • Mr. Keith J. Ebling, EVP, Gen. Counsel & Sec. (Age 49)

Has Dentsply Sirona been receiving favorable news coverage?

Media stories about XRAY stock have trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dentsply Sirona earned a news sentiment score of 0.03 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 46.97 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Dentsply Sirona?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dentsply Sirona's stock price today?

One share of XRAY stock can currently be purchased for approximately $50.62.

How big of a company is Dentsply Sirona?

Dentsply Sirona has a market capitalization of $11.41 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. Dentsply Sirona employs 16,100 workers across the globe.

How can I contact Dentsply Sirona?

Dentsply Sirona's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]


MarketBeat Community Rating for Dentsply Sirona (XRAY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  250 (Vote Outperform)
Underperform Votes:  247 (Vote Underperform)
Total Votes:  497
MarketBeat's community ratings are surveys of what our community members think about Dentsply Sirona and other stocks. Vote "Outperform" if you believe XRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dentsply Sirona (NASDAQ:XRAY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for Dentsply Sirona in the last 12 months. Their average twelve-month price target is $67.00, suggesting that the stock has a possible upside of 32.36%. The high price target for XRAY is $81.00 and the low price target for XRAY is $55.00. There are currently 1 sell rating, 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.572.572.542.50
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $67.00$67.0769$68.9167$64.8889
Price Target Upside: 32.36% upside18.87% upside10.00% upside6.95% upside

Dentsply Sirona (NASDAQ:XRAY) Consensus Price Target History

Price Target History for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/16/2018Jefferies GroupReiterated RatingBuyLowView Rating Details
4/5/2018Cleveland ResearchReiterated RatingHoldLowView Rating Details
3/27/2018Barrington ResearchReiterated RatingBuy$69.00MediumView Rating Details
3/27/2018HC WainwrightSet Price TargetHold$63.00MediumView Rating Details
3/8/2018BarclaysInitiated CoverageEqual Weight -> Equal Weight$62.00LowView Rating Details
3/5/2018JPMorgan ChaseLower Price TargetOverweight -> Overweight$75.00 -> $70.00LowView Rating Details
3/2/2018Credit Suisse GroupLower Price TargetOutperform -> Outperform$73.00 -> $69.00HighView Rating Details
12/8/2017Deutsche BankInitiated CoverageBuy -> Buy$81.00LowView Rating Details
11/28/2017StephensInitiated CoverageOverweight$75.00LowView Rating Details
11/6/2017Stifel NicolausBoost Price TargetBuy$66.00 -> $70.00N/AView Rating Details
10/19/2017Robert W. BairdSet Price TargetBuy$63.00N/AView Rating Details
10/6/2017Morgan StanleyReiterated RatingOverweight$67.00 -> $69.00N/AView Rating Details
8/10/2017UBSReiterated RatingNeutral$62.00 -> $59.00LowView Rating Details
5/23/2017Goldman SachsDowngradeNeutral -> Sell$60.00 -> $55.00MediumView Rating Details
9/12/2016Bank of AmericaInitiated CoverageBuy$70.00N/AView Rating Details
6/27/2016Piper JaffrayReiterated RatingBuyN/AView Rating Details
(Data available from 4/19/2016 forward)

Earnings

Dentsply Sirona (NASDAQ:XRAY) Earnings History and Estimates Chart

Earnings by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Earnings Estimates

2018 EPS Consensus Estimate: $2.73
2019 EPS Consensus Estimate: $3.00
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$0.42$0.43$0.43
Q2 20184$0.65$0.69$0.67
Q3 20184$0.75$0.77$0.76
Q4 20184$0.86$0.89$0.87
Q1 20193$0.50$0.65$0.58
Q2 20193$0.74$0.79$0.76
Q3 20193$0.77$0.84$0.80
Q4 20193$0.80$0.97$0.87

Dentsply Sirona (NASDAQ XRAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018$0.53N/AView Earnings Details
3/1/2018Q4 2017$0.81$0.82$1.0607 billion$1.0910 billionViewListenView Earnings Details
11/3/2017Q3 2017$0.66$0.70$978.99 million$1.0092 billionViewN/AView Earnings Details
8/9/2017Q2 2017$0.65$0.65$1.0032 billion$992.70 millionViewListenView Earnings Details
5/9/2017Q1 17$0.50$0.49$916.55 million$900.50 millionViewListenView Earnings Details
2/17/2017Q4 2016$0.65$0.67$1.0192 billion$996.50 millionViewListenView Earnings Details
11/4/2016Q316$0.63$0.66$967.68 million$954.20 millionViewListenView Earnings Details
8/5/2016Q216$0.70$0.76$1.03 billion$1.02 billionViewListenView Earnings Details
5/6/2016Q1$0.63$0.69$741.80 million$772.60 millionViewN/AView Earnings Details
2/12/2016Q415$0.65$0.65$687.35 million$671.10 millionViewListenView Earnings Details
10/28/2015Q3$0.63$0.66$667.00 million$648.90 millionViewListenView Earnings Details
7/30/2015Q215$0.68$0.73$715.49 million$698.00 millionViewListenView Earnings Details
5/6/2015Q115$0.57$0.59$690.16 million$656.30 millionViewListenView Earnings Details
2/18/2015Q414$0.61$0.60$751.04 million$719.00 millionViewListenView Earnings Details
10/29/2014Q314$0.60$0.62$725.83 million$708.00 millionViewListenView Earnings Details
7/31/2014Q2$0.68$0.69$782.86 million$765.20 millionViewListenView Earnings Details
5/6/2014Q1$0.56$0.59$747.27 million$730.10 millionViewListenView Earnings Details
2/18/2014Q4$0.61$0.61$767.89 million$753.70 millionViewListenView Earnings Details
10/29/2013Q313$0.56$0.57$716.13 million$704.00 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.65$0.66$782.73 million$761.00 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.56$0.52$732.87 million$732.10 millionViewListenView Earnings Details
2/20/2013Q4 2012$0.56$0.56$748.56 million$753.30 millionViewListenView Earnings Details
10/25/2012$0.50$0.51ViewN/AView Earnings Details
7/31/2012$0.57$0.62ViewN/AView Earnings Details
5/1/2012$0.52$0.52ViewN/AView Earnings Details
2/16/2012$0.52$0.51ViewN/AView Earnings Details
10/27/2011$0.43$0.46ViewN/AView Earnings Details
7/28/2011$0.51$0.55ViewN/AView Earnings Details
4/28/2011$0.48$0.49ViewN/AView Earnings Details
2/9/2011$0.50$0.51ViewN/AView Earnings Details
10/28/2010Q3 2010$0.45$0.45ViewN/AView Earnings Details
7/29/2010Q2 2010$0.51$0.50ViewN/AView Earnings Details
4/29/2010Q1 2010$0.45$0.44ViewN/AView Earnings Details
2/10/2010Q4 2009$0.48$0.48ViewN/AView Earnings Details
10/28/2009Q3 2009$0.44$0.44ViewN/AView Earnings Details
7/29/2009Q2 2009$0.48$0.49ViewN/AView Earnings Details
4/30/2009Q1 2009$0.43$0.43ViewN/AView Earnings Details
2/4/2009Q4 2008$0.46$0.45ViewN/AView Earnings Details
10/28/2008Q3 2008$0.44$0.46ViewN/AView Earnings Details
7/29/2008Q2 2008$0.49$0.53ViewN/AView Earnings Details
4/30/2008Q1 2008$0.43$0.45ViewN/AView Earnings Details
2/5/2008Q4 2007$0.44$0.46ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Dentsply Sirona (NASDAQ:XRAY) Dividend Information

Dentsply Sirona pays an annual dividend of $0.35 per share, with a dividend yield of 0.69%. XRAY's most recent quarterly dividend payment was Friday, April 13. Dentsply Sirona pays out 13.16% of its earnings out as a dividend.
Most Recent Dividend:4/13/2018
Annual Dividend:$0.35
Dividend Yield:0.69%
Payout Ratio:13.16% (Trailing 12 Months of Earnings)
12.87% (Based on This Year's Estimates)
11.59% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2018quarterly$0.08750.7%3/28/20183/29/20184/13/2018
12/12/2017quarterly$0.08750.53%12/28/201712/29/20171/12/2018
6/28/2017quarterly$0.08750.54%9/28/20179/29/201710/13/2017
6/22/2017quarterly$0.08750.55%6/28/20176/30/20177/14/2017
2/17/2017quarterly$0.08750.56%3/29/20173/31/20174/13/2017
12/15/2016quarterly$0.07750.52%12/28/201612/30/20161/13/2017
9/22/2016$0.07759/28/20169/30/201610/14/2016
4/11/2016$0.07806/22/20166/24/20167/8/2016
3/3/2016$0.07803/22/20163/25/20164/8/2016
10/1/2015$0.072012/22/201512/25/20151/8/2016
7/29/2015quarterly$0.07259/23/20159/25/201510/9/2015
5/20/2015quarterly$0.07250.55%6/24/20156/26/20157/10/2015
2/24/2015quarterly$0.07250.54%3/25/20153/27/20154/10/2015
9/25/2014quarterly$0.06630.58%12/23/201412/26/20141/9/2015
8/1/2014quarterly$0.06630.57%9/24/20149/26/201410/10/2014
5/22/2014quarterly$0.06630.57%6/25/20146/27/20147/11/2014
2/18/2014quarterly$0.06630.59%3/26/20143/28/20144/11/2014
9/27/2013quarterly$0.06250.58%12/24/201312/27/20131/10/2014
8/1/2013quarterly$0.06250.58%9/25/20139/27/201310/11/2013
5/23/2013quarterly$0.06250.6%6/26/20136/28/20137/12/2013
2/27/2013quarterly$0.06250.61%3/26/20133/29/20134/12/2013
(Data available from 1/1/2013 forward)

Insider Trades

Dentsply Sirona (NASDAQ XRAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.93%
Institutional Ownership Percentage: 97.79%
Insider Trading History for Dentsply Sirona (NASDAQ:XRAY)
Insider Trading History for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ XRAY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/8/2018Eric BrandtDirectorSell6,409$68.04$436,068.3612,073View SEC Filing  
11/13/2017Francis J LungerDirectorSell8,900$65.90$586,510.00View SEC Filing  
11/13/2017Mark ThiererInsiderBuy77,000$66.04$5,085,080.00View SEC Filing  
11/13/2017Nicholas W AlexosCFOBuy50,000$65.85$3,292,500.00View SEC Filing  
4/24/2017James G MoschCEOSell50,600$63.49$3,212,594.00105,083View SEC Filing  
4/7/2017Christopher T ClarkCEOSell89,700$62.67$5,621,499.00112,067View SEC Filing  
3/9/2017Ulrich MichelInsiderSell24,000$62.84$1,508,160.0094,067View SEC Filing  
3/2/2017Eric BrandtDirectorSell2,941$64.35$189,253.354,722View SEC Filing  
3/1/2017Bret W WiseInsiderSell146,900$64.17$9,426,573.00142,121View SEC Filing  
2/17/2017Arthur D KowaloffDirectorSell27,213$62.00$1,687,206.0055,692View SEC Filing  
2/17/2017Christopher T ClarkCEOSell64,500$60.70$3,915,150.0055,916View SEC Filing  
11/17/2016James G MoschCEOSell30,400$60.93$1,852,272.0075,283View SEC Filing  
9/6/2016Rainer BerthanVPSell5,000$61.12$305,600.0034,370View SEC Filing  
8/25/2016Maureen J MacinnisSVPSell45,100$60.55$2,730,805.0036,730View SEC Filing  
8/23/2016Maureen J MacinnisSVPSell17,650$60.61$1,069,766.5019,630View SEC Filing  
6/2/2016Rainer BerthanVPSell6,464$62.56$404,387.8439,341View SEC Filing  
5/26/2016Michael C AlfanoDirectorSell3,000$61.58$184,740.008,758View SEC Filing  
5/16/2016Harry M Jansen Kraemer JrDirectorSell27,213$62.17$1,691,832.2158,262View SEC Filing  
3/29/2016Arthur D KowaloffDirectorSell13,006$62.00$806,372.0042,785View SEC Filing  
11/18/2015Deborah RasinVPSell4,500$60.56$272,520.004,429View SEC Filing  
11/4/2015Michael C AlfanoDirectorSell2,500$62.15$155,375.008,737View SEC Filing  
11/3/2015Deborah RasinVPSell14,000$61.70$863,800.008,929View SEC Filing  
3/30/2015Christopher T ClarkInsiderSell85,566$51.18$4,379,267.88View SEC Filing  
2/20/2015Deborah RasinVPSell11,000$52.47$577,170.00View SEC Filing  
2/20/2015Michael J ColemanDirectorSell18,000$52.47$944,460.00View SEC Filing  
1/9/2015Robert J SizeVPSell9,200$52.97$487,324.00View SEC Filing  
12/8/2014Leslie A JonesDirectorSell18,000$55.45$998,100.00View SEC Filing  
12/4/2014Albert SterkenburgVPSell23,200$55.62$1,290,384.00View SEC Filing  
11/7/2014Michael C AlfanoDirectorSell20,000$51.23$1,024,600.00View SEC Filing  
11/5/2014James G MoschVPSell55,042$51.25$2,820,902.50View SEC Filing  
11/4/2014Francis J LungerDirectorSell9,160$50.90$466,244.00View SEC Filing  
10/31/2014Albert SterkenburgVPSell2,000$50.51$101,020.00View SEC Filing  
10/31/2014John C Miles IIDirectorSell20,000$50.65$1,013,000.00View SEC Filing  
8/25/2014Leslie A JonesDirectorSell2,000$48.30$96,600.00View SEC Filing  
7/3/2014Christopher T ClarkInsiderSell27,521$47.74$1,313,852.54View SEC Filing  
5/30/2014Michael C AlfanoDirectorSell2,764$47.25$130,599.00View SEC Filing  
5/19/2014Leslie JonesDirectorSell2,000$46.49$92,980.0095,892View SEC Filing  
5/12/2014Robert SizeVPSell5,049$46.29$233,718.2111,588View SEC Filing  
12/11/2013Bret WiseChairmanSell90,000$48.50$4,365,000.0021,724View SEC Filing  
12/9/2013Francis LungerDirectorSell18,000$47.66$857,880.004,322View SEC Filing  
12/6/2013Bret WiseChairmanSell24,323$47.66$1,159,234.1830,294View SEC Filing  
12/2/2013Bret WiseChairmanSell66,761$47.53$3,173,150.3330,294View SEC Filing  
12/2/2013William HechtDirectorSell18,000$47.49$854,820.0018,000View SEC Filing  
11/8/2013Leslie JonesDirectorSell2,000$47.68$95,360.0097,892View SEC Filing  
10/21/2013Robert J SizeVPSell14,262$46.00$656,052.00View SEC Filing  
9/11/2013Robert SizeVPSell8,200$45.00$369,000.0011,501View SEC Filing  
9/10/2013James G MoschVPSell41,836$43.95$1,838,692.20View SEC Filing  
7/31/2013Christopher T ClarkInsiderSell20,918$43.00$899,474.00View SEC Filing  
7/31/2013Eric BrandtDirectorSell18,000$43.00$774,000.00View SEC Filing  
7/9/2013Christopher T ClarkInsiderSell20,918$42.00$878,556.00View SEC Filing  
6/3/2013Leslie A JonesDirectorSell2,840$41.76$118,598.40View SEC Filing  
3/12/2013Paula H CholmondeleyDirectorSell9,000$42.70$384,300.00View SEC Filing  
12/21/2012Bret W WiseChairmanSell4,349$40.50$176,134.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Dentsply Sirona (NASDAQ XRAY) News Headlines

Source:
DateHeadline
Q2 2018 EPS Estimates for Dentsply Sirona Boosted by Analyst (XRAY)Q2 2018 EPS Estimates for Dentsply Sirona Boosted by Analyst (XRAY)
www.americanbankingnews.com - April 18 at 8:12 AM
Factors of Influence in 2018, Key Indicators and Opportunity within Cerner ...Factors of Influence in 2018, Key Indicators and Opportunity within Cerner ...
globenewswire.com - April 17 at 8:06 AM
Jefferies Group Analysts Reduce Earnings Estimates for Dentsply Sirona (XRAY)Jefferies Group Analysts Reduce Earnings Estimates for Dentsply Sirona (XRAY)
www.americanbankingnews.com - April 17 at 6:54 AM
Dentsply Sirona (XRAY) Earns "Buy" Rating from Jefferies GroupDentsply Sirona (XRAY) Earns "Buy" Rating from Jefferies Group
www.americanbankingnews.com - April 16 at 9:16 PM
Head-To-Head Review: Biolase (BIOL) & Dentsply Sirona (XRAY)Head-To-Head Review: Biolase (BIOL) & Dentsply Sirona (XRAY)
www.americanbankingnews.com - April 16 at 11:38 AM
Dentsply Sirona: Let The Dip Deepen Before BuyingDentsply Sirona: Let The Dip Deepen Before Buying
seekingalpha.com - April 16 at 8:02 AM
Biolase (BIOL) & Dentsply Sirona (XRAY) Financial ContrastBiolase (BIOL) & Dentsply Sirona (XRAY) Financial Contrast
www.americanbankingnews.com - April 13 at 11:51 AM
Active-Investors: Free Post Earnings Research Report: DENTSPLYs Quarterly Sales Jumped 9.5%; Adjusted EPS Advanced 22%Active-Investors: Free Post Earnings Research Report: DENTSPLY's Quarterly Sales Jumped 9.5%; Adjusted EPS Advanced 22%
www.finanznachrichten.de - April 12 at 5:56 PM
Free Post Earnings Research Report: DENTSPLY’s Quarterly Sales Jumped 9.5%; Adjusted EPS Advanced 22%Free Post Earnings Research Report: DENTSPLY’s Quarterly Sales Jumped 9.5%; Adjusted EPS Advanced 22%
finance.yahoo.com - April 12 at 8:03 AM
Dentsply Sirona (XRAY) Expected to Post Quarterly Sales of $950.06 MillionDentsply Sirona (XRAY) Expected to Post Quarterly Sales of $950.06 Million
www.americanbankingnews.com - April 11 at 4:51 AM
Dentsply Sirona (XRAY) Rating Reiterated by HC WainwrightDentsply Sirona (XRAY) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - April 10 at 5:38 PM
Will Dentsply Sirona Stock Recover from Recent Declines?Will Dentsply Sirona Stock Recover from Recent Declines?
finance.yahoo.com - April 10 at 8:08 AM
Dentsply Sirona (XRAY) Expected to Announce Earnings of $0.44 Per ShareDentsply Sirona (XRAY) Expected to Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - April 9 at 5:23 AM
HC Wainwright Reiterates Buy Rating for Dentsply Sirona (XRAY)HC Wainwright Reiterates Buy Rating for Dentsply Sirona (XRAY)
www.americanbankingnews.com - April 8 at 11:04 AM
DENTSPLY SIRONAs (XRAY) "Hold" Rating Reiterated at Cleveland ResearchDENTSPLY SIRONA's (XRAY) "Hold" Rating Reiterated at Cleveland Research
www.americanbankingnews.com - April 5 at 10:33 AM
Q1 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Reduced by AnalystQ1 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Reduced by Analyst
www.americanbankingnews.com - April 4 at 7:04 AM
Head to Head Comparison: Straumann (SAUHF) & DENTSPLY SIRONA (XRAY)Head to Head Comparison: Straumann (SAUHF) & DENTSPLY SIRONA (XRAY)
www.americanbankingnews.com - April 3 at 9:20 PM
DENTSPLY SIRONA (XRAY) Upgraded by Barrington Research to "Outperform"DENTSPLY SIRONA (XRAY) Upgraded by Barrington Research to "Outperform"
www.americanbankingnews.com - April 1 at 8:42 PM
FY2020 Earnings Estimate for DENTSPLY SIRONA Inc Issued By William Blair (XRAY)FY2020 Earnings Estimate for DENTSPLY SIRONA Inc Issued By William Blair (XRAY)
www.americanbankingnews.com - March 29 at 8:46 AM
Q2 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Increased by AnalystQ2 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Increased by Analyst
www.americanbankingnews.com - March 29 at 7:55 AM
Q1 2018 Earnings Forecast for DENTSPLY SIRONA Inc (XRAY) Issued By William BlairQ1 2018 Earnings Forecast for DENTSPLY SIRONA Inc (XRAY) Issued By William Blair
www.americanbankingnews.com - March 28 at 6:38 AM
DENTSPLY SIRONA Inc (XRAY) Forecasted to Earn Q1 2018 Earnings of $0.42 Per ShareDENTSPLY SIRONA Inc (XRAY) Forecasted to Earn Q1 2018 Earnings of $0.42 Per Share
www.americanbankingnews.com - March 28 at 6:38 AM
DENTSPLY to Acquire OraMetrix, Boost CAD-CAM Dental UnitDENTSPLY to Acquire OraMetrix, Boost CAD-CAM Dental Unit
finance.yahoo.com - March 27 at 5:26 PM
DENTSPLY SIRONA (XRAY) PT Set at $63.00 by HC WainwrightDENTSPLY SIRONA (XRAY) PT Set at $63.00 by HC Wainwright
www.americanbankingnews.com - March 27 at 10:01 AM
DENTSPLY SIRONA (XRAY) Earns "Buy" Rating from Barrington ResearchDENTSPLY SIRONA (XRAY) Earns "Buy" Rating from Barrington Research
www.americanbankingnews.com - March 27 at 9:31 AM
BidaskClub Lowers DENTSPLY SIRONA (XRAY) to SellBidaskClub Lowers DENTSPLY SIRONA (XRAY) to Sell
www.americanbankingnews.com - March 26 at 10:58 PM
Dentsply Sirona (XRAY) Reports Acquisition of Technology Solutions Provider OraMetrixDentsply Sirona (XRAY) Reports Acquisition of Technology Solutions Provider OraMetrix
www.streetinsider.com - March 26 at 5:34 PM
Heres Why You Should Steer Clear of DENTSPLY (XRAY) for NowHere's Why You Should Steer Clear of DENTSPLY (XRAY) for Now
finance.yahoo.com - March 26 at 5:34 PM
DENTSPLY SIRONA Inc (XRAY) Receives Average Recommendation of "Hold" from AnalystsDENTSPLY SIRONA Inc (XRAY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 26 at 3:05 AM
DENTSPLY SIRONA Inc (XRAY) Expected to Announce Quarterly Sales of $961.48 MillionDENTSPLY SIRONA Inc (XRAY) Expected to Announce Quarterly Sales of $961.48 Million
www.americanbankingnews.com - March 25 at 8:38 AM
DENTSPLY SIRONA (XRAY) Downgraded by BidaskClub to Strong SellDENTSPLY SIRONA (XRAY) Downgraded by BidaskClub to Strong Sell
www.americanbankingnews.com - March 24 at 7:53 PM
Worldwide CBCT Dental Imaging Market Financial Overview, Dentistry Sector Top 8 Players Management, Size and Share 2022 InsightWorldwide CBCT Dental Imaging Market Financial Overview, Dentistry Sector Top 8 Players Management, Size and Share 2022 Insight
www.marketwatch.com - March 24 at 5:28 PM
DENTSPLY SIRONA Becomes Oversold (XRAY) - NasdaqDENTSPLY SIRONA Becomes Oversold (XRAY) - Nasdaq
www.nasdaq.com - March 23 at 8:05 AM
Zacks: Brokerages Anticipate DENTSPLY SIRONA Inc (XRAY) Will Announce Earnings of $0.48 Per ShareZacks: Brokerages Anticipate DENTSPLY SIRONA Inc (XRAY) Will Announce Earnings of $0.48 Per Share
www.americanbankingnews.com - March 23 at 3:22 AM
Why Innovation Matters to Dentsply Sirona—Now More Than EverWhy Innovation Matters to Dentsply Sirona—Now More Than Ever
finance.yahoo.com - March 20 at 8:07 AM
New Strong Sell Stocks for March 19thNew Strong Sell Stocks for March 19th
www.zacks.com - March 19 at 8:05 AM
Understanding Dentsply Sirona’s New Organizational StructureUnderstanding Dentsply Sirona’s New Organizational Structure
finance.yahoo.com - March 19 at 8:05 AM
Behind Dentsply Sirona’s Total Impairment Charges in 2017Behind Dentsply Sirona’s Total Impairment Charges in 2017
finance.yahoo.com - March 16 at 8:02 AM
Quotidian Technical Highlights on Selected Medical Supplies Stocks -- Baxter, ConforMIS, DENTSPLY SIRONA, and HaemoneticsQuotidian Technical Highlights on Selected Medical Supplies Stocks -- Baxter, ConforMIS, DENTSPLY SIRONA, and Haemonetics
www.bizjournals.com - March 13 at 7:30 PM
DENTSPLY SIRONA (XRAY) Coverage Initiated by Analysts at BarclaysDENTSPLY SIRONA (XRAY) Coverage Initiated by Analysts at Barclays
www.americanbankingnews.com - March 9 at 12:43 AM
Jefferies Group Comments on DENTSPLY SIRONA Incs Q3 2018 Earnings (XRAY)Jefferies Group Comments on DENTSPLY SIRONA Inc's Q3 2018 Earnings (XRAY)
www.americanbankingnews.com - March 8 at 7:50 AM
Barrington Research Comments on DENTSPLY SIRONA Incs Q1 2018 Earnings (XRAY)Barrington Research Comments on DENTSPLY SIRONA Inc's Q1 2018 Earnings (XRAY)
www.americanbankingnews.com - March 8 at 7:29 AM
Jefferies Group Research Analysts Lower Earnings Estimates for DENTSPLY SIRONA Inc (XRAY)Jefferies Group Research Analysts Lower Earnings Estimates for DENTSPLY SIRONA Inc (XRAY)
www.americanbankingnews.com - March 7 at 7:32 AM
Q1 2018 Earnings Estimate for DENTSPLY SIRONA Inc (XRAY) Issued By William BlairQ1 2018 Earnings Estimate for DENTSPLY SIRONA Inc (XRAY) Issued By William Blair
www.americanbankingnews.com - March 7 at 7:26 AM
Ruane Cunniff Comments on Dentsply SironaRuane Cunniff Comments on Dentsply Sirona
finance.yahoo.com - March 6 at 5:51 PM
Sequoia Fund Managements Discussion of Fund PerformanceSequoia Fund Management's Discussion of Fund Performance
finance.yahoo.com - March 6 at 5:51 PM
DENTSPLY SIRONA Inc (XRAY) Holdings Cut by Independent Franchise Partners LLPDENTSPLY SIRONA Inc (XRAY) Holdings Cut by Independent Franchise Partners LLP
www.americanbankingnews.com - March 6 at 9:04 AM
Monday Sector Laggards: Services, Healthcare - NasdaqMonday Sector Laggards: Services, Healthcare - Nasdaq
www.nasdaq.com - March 6 at 8:02 AM
Align Technology’s Capital Allocation StrategyAlign Technology’s Capital Allocation Strategy
finance.yahoo.com - March 6 at 8:02 AM
William Blair Analysts Decrease Earnings Estimates for DENTSPLY SIRONA Inc (XRAY)William Blair Analysts Decrease Earnings Estimates for DENTSPLY SIRONA Inc (XRAY)
www.americanbankingnews.com - March 6 at 7:22 AM

SEC Filings

Dentsply Sirona (NASDAQ:XRAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Dentsply Sirona (NASDAQ:XRAY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Dentsply Sirona (NASDAQ XRAY) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.